Atlas Trials

A Study to Evaluate the Relative Bioavailability of STI-1558 and the Effect of Itraconazole and Rifampin on the Pharmacokinetics of STI-1558

Clinical trial NCT05685719 · COMPLETED

Trial details

NCT number
NCT05685719
Sponsor
Zhejiang ACEA Pharmaceutical Co. Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19 Pneumonia
Start date
2023-01-04
Primary completion
2023-03-15
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.